Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2025 · 10-Q
Revenue$289.46M$289.46M+4.5% vs Q1 2024 Net Income$33.60M$33.60M−34.1% vs Q1 2024 EPS Diluted$0.21$0.21−32.3% vs Q1 2024 Gross Profit$183,017,000−1.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$63,889,000+7.6% Free Cash Flowderived$54,717,000+19.5% Margins · derivedGross margin63.2%−3.6 pt vs Q1 2024
Operating margin13.8%−6.4 pt vs Q1 2024
Net margin11.6%−6.8 pt vs Q1 2024
ended Sep 30, 2024 · filed Nov 5, 2024 · 36 d after period end